118 related articles for article (PubMed ID: 30077906)
1. Immunotoxicity assessment of ordered mesoporous carbon nanoparticles modified with PVP/PEG.
Li X; Wang L; She L; Sun L; Ma Z; Chen M; Hu P; Wang D; Yang F
Colloids Surf B Biointerfaces; 2018 Nov; 171():485-493. PubMed ID: 30077906
[TBL] [Abstract][Full Text] [Related]
2. Mesoporous Carbon Nanoparticles as Multi-functional Carriers for Cancer Therapy Compared with Mesoporous Silica Nanoparticles.
Zhou M; Zhao Q; Wu Y; Feng S; Wang D; Zhang Y; Wang S
AAPS PharmSciTech; 2020 Jan; 21(2):42. PubMed ID: 31897882
[TBL] [Abstract][Full Text] [Related]
3. A Comparative Study of the Use of Mesoporous Carbon and Mesoporous Silica as Drug Carriers for Oral Delivery of the Water-Insoluble Drug Carvedilol.
Han C; Huang H; Dong Y; Sui X; Jian B; Zhu W
Molecules; 2019 May; 24(9):. PubMed ID: 31067732
[TBL] [Abstract][Full Text] [Related]
4. The immunotoxicity of graphene oxides and the effect of PVP-coating.
Zhi X; Fang H; Bao C; Shen G; Zhang J; Wang K; Guo S; Wan T; Cui D
Biomaterials; 2013 Jul; 34(21):5254-61. PubMed ID: 23566800
[TBL] [Abstract][Full Text] [Related]
5. Nanocrystal formulations of a poorly soluble drug. 1. In vitro characterization of stability, stabilizer adsorption and uptake in liver cells.
Sigfridsson K; Skantze U; Skantze P; Johansson S; Grant I; Smedsrød B; Fuglesteg B; Elvevold K; Lindfors L
Int J Pharm; 2017 Feb; 518(1-2):29-40. PubMed ID: 28012994
[TBL] [Abstract][Full Text] [Related]
6. Surface Modification of Polysaccharide-Based Nanoparticles with PEG and Dextran and the Effects on Immune Cell Binding and Stimulatory Characteristics.
Bamberger D; Hobernik D; Konhäuser M; Bros M; Wich PR
Mol Pharm; 2017 Dec; 14(12):4403-4416. PubMed ID: 29063757
[TBL] [Abstract][Full Text] [Related]
7. Structurally ordered mesoporous carbon nanoparticles as transmembrane delivery vehicle in human cancer cells.
Kim TW; Chung PW; Slowing II; Tsunoda M; Yeung ES; Lin VS
Nano Lett; 2008 Nov; 8(11):3724-7. PubMed ID: 18954128
[TBL] [Abstract][Full Text] [Related]
8. Glucan adsorption on mesoporous carbon nanoparticles: effect of chain length and internal surface.
Chung PW; Charmot A; Gazit OM; Katz A
Langmuir; 2012 Oct; 28(43):15222-32. PubMed ID: 23020524
[TBL] [Abstract][Full Text] [Related]
9. Modulation of in vitro phagocytic uptake and immunogenicity potential of modified Herceptin
Badkas A; Frank E; Zhou Z; Jafari M; Chandra H; Sriram V; Lee JY; Yadav JS
Colloids Surf B Biointerfaces; 2018 Feb; 162():271-278. PubMed ID: 29216514
[TBL] [Abstract][Full Text] [Related]
10. Effect of poly(N-vinyl-pyrrolidone)-block-poly(D,L-lactide) as coating agent on the opsonization, phagocytosis, and pharmacokinetics of biodegradable nanoparticles.
Gaucher G; Asahina K; Wang J; Leroux JC
Biomacromolecules; 2009 Feb; 10(2):408-16. PubMed ID: 19133718
[TBL] [Abstract][Full Text] [Related]
11. The properties of mesoporous silica nanoparticles functionalized with different PEG-chain length via the disulfide bond linker and drug release in glutathione medium.
Xie Z; Gong H; Liu M; Zhu H; Sun H
J Biomater Sci Polym Ed; 2016; 27(1):55-68. PubMed ID: 26540096
[TBL] [Abstract][Full Text] [Related]
12. The influence of PEG chain length and targeting moiety on antibody-mediated delivery of nanoparticle vaccines to human dendritic cells.
Cruz LJ; Tacken PJ; Fokkink R; Figdor CG
Biomaterials; 2011 Oct; 32(28):6791-803. PubMed ID: 21724247
[TBL] [Abstract][Full Text] [Related]
13. Preparation of multifunctional PEG-graft-Halloysite Nanotubes for Controlled Drug Release, Tumor Cell Targeting, and Bio-imaging.
Yamina AM; Fizir M; Itatahine A; He H; Dramou P
Colloids Surf B Biointerfaces; 2018 Oct; 170():322-329. PubMed ID: 29936385
[TBL] [Abstract][Full Text] [Related]
14. Optical imaging and anticancer chemotherapy through carbon dot created hollow mesoporous silica nanoparticles.
Kang MS; Singh RK; Kim TH; Kim JH; Patel KD; Kim HW
Acta Biomater; 2017 Jun; 55():466-480. PubMed ID: 28373086
[TBL] [Abstract][Full Text] [Related]
15. Hollow mesoporous carbon as a near-infrared absorbing carrier compared with mesoporous carbon nanoparticles for chemo-photothermal therapy.
Li X; Yan Y; Lin Y; Jiao J; Wang D; Di D; Zhang Y; Jiang T; Zhao Q; Wang S
J Colloid Interface Sci; 2017 May; 494():159-169. PubMed ID: 28157634
[TBL] [Abstract][Full Text] [Related]
16. Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug-polymer interactions.
Karavas E; Georgarakis E; Sigalas MP; Avgoustakis K; Bikiaris D
Eur J Pharm Biopharm; 2007 Jun; 66(3):334-47. PubMed ID: 17267194
[TBL] [Abstract][Full Text] [Related]
17. Dextran-based therapeutic nanoparticles for hepatic drug delivery.
Foerster F; Bamberger D; Schupp J; Weilbächer M; Kaps L; Strobl S; Radi L; Diken M; Strand D; Tuettenberg A; Wich PR; Schuppan D
Nanomedicine (Lond); 2016 Oct; 11(20):2663-2677. PubMed ID: 27628057
[TBL] [Abstract][Full Text] [Related]
18. The comparative effects of mesoporous silica nanoparticles and colloidal silica on inflammation and apoptosis.
Lee S; Yun HS; Kim SH
Biomaterials; 2011 Dec; 32(35):9434-43. PubMed ID: 21889200
[TBL] [Abstract][Full Text] [Related]
19. Mitoxantrone-loaded chitosan/hyaluronate polyelectrolyte nanoparticles decorated with amphiphilic PEG derivates for long-circulating effect.
Wang J; Asghar S; Jin X; Chen Z; Huang L; Ping Q; Zong L; Xiao Y
Colloids Surf B Biointerfaces; 2018 Nov; 171():468-477. PubMed ID: 30077147
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor alpha blocking peptide loaded PEG-PLGA nanoparticles: preparation and in vitro evaluation.
Yang A; Yang L; Liu W; Li Z; Xu H; Yang X
Int J Pharm; 2007 Feb; 331(1):123-32. PubMed ID: 17097246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
